- Home
- NXPLW vs VLY Comparison
NXPLW vs VLY Comparison
Compare NXPLW & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- VLY
- Stock Information
- Founded
- NXPLW N/A
- VLY 1927
- Country
- NXPLW United States
- VLY United States
- Employees
- NXPLW N/A
- VLY N/A
- Industry
- NXPLW Telecommunications Equipment
- VLY Major Banks
- Sector
- NXPLW Telecommunications
- VLY Finance
- Exchange
- NXPLW Nasdaq
- VLY Nasdaq
- Market Cap
- NXPLW N/A
- VLY N/A
- IPO Year
- NXPLW N/A
- VLY N/A
- Fundamental
- Price
- NXPLW $0.21
- VLY $9.60
- Analyst Decision
- NXPLW
- VLY Buy
- Analyst Count
- NXPLW 0
- VLY 13
- Target Price
- NXPLW N/A
- VLY $10.31
- AVG Volume (30 Days)
- NXPLW 6.4K
- VLY 8.6M
- Earning Date
- NXPLW 03-31-2025
- VLY 01-23-2025
- Dividend Yield
- NXPLW N/A
- VLY 4.62%
- EPS Growth
- NXPLW N/A
- VLY N/A
- EPS
- NXPLW N/A
- VLY 0.69
- Revenue
- NXPLW $66,482,000.00
- VLY $1,518,099,000.00
- Revenue This Year
- NXPLW N/A
- VLY N/A
- Revenue Next Year
- NXPLW N/A
- VLY $8.52
- P/E Ratio
- NXPLW N/A
- VLY $13.82
- Revenue Growth
- NXPLW 179.89
- VLY N/A
- 52 Week Low
- NXPLW $0.25
- VLY $6.47
- 52 Week High
- NXPLW $0.26
- VLY $11.10
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- VLY 47.96
- Support Level
- NXPLW N/A
- VLY $9.76
- Resistance Level
- NXPLW N/A
- VLY $10.13
- Average True Range (ATR)
- NXPLW 0.00
- VLY 0.24
- MACD
- NXPLW 0.00
- VLY -0.06
- Stochastic Oscillator
- NXPLW 0.00
- VLY 17.61
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.